ZUG, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a…
100% of evaluable participants at Month 6 achieved target absolute neutrophil count (ANC) increase with once-daily, oral mavorixafor +/- stable-dose…
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and…
GEN2’s dose-escalation trial, GVO-1102, will establish the Recommended Phase 2 Dose (RP2D), followed immediately by an expansion phase into 3…
Patient screening underway in Ntrust-1, the first U.S.-based clinical trial of an engineered NK cell therapy for the treatment of…
Collaboration focuses on research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases ANEW’s…
DUSSELDORF, Germany, June 27, 2024 /PRNewswire/ -- Geekplus, the global leader in mobile robot and smart logistics solutions, in collaboration…
Partner SMS Pharma will market the three products in the SiderAL® line under the trade name Sucrosom®, which is based on…
Parkinson's disease research, sponsored by King's College London, verifies clinical observation data using the Algorand blockchain LONDON, June 27, 2024…
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024Northvale, New Jersey--(Newsfile Corp. -…